Pharmaceuticals

Thin Film Drug Manufacturing Market Future Outlook: Strong Growth Expected Toward $13.35 Billion by 2030

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the thin film drug manufacturing market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Thin Film Drug Manufacturing Market?

The thin film drug manufacturing market has observed significant expansion in recent years. It is anticipated to grow from $8.71 billion in 2025 to $9.51 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 9.2%. This market’s historical growth can be attributed to challenges associated with swallowing conventional tablets, an increasing emphasis on patient adherence, the early integration of oral dissolving technologies, a heightened demand for rapid onset therapies, and the expansion of hospital pharmacy distribution networks.

The thin film drug manufacturing market is projected to experience substantial expansion over the coming years. Its valuation is anticipated to reach $13.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. This projected growth during the forecast period is fueled by several factors, including innovations in thin film formulation technologies, the increasing occurrence of neurological conditions, the broadening scope of e-commerce for pharmaceutical distribution, greater investment in new drug delivery methods, and a rise in regulatory clearances for thin film medications. Key trends expected within this period encompass the growing preference for oral thin films designed for swift drug release, an escalating need for patient-convenient dosage formats, wider application of thin films in addressing neurological and CNS disorders, the development of taste-masked and orally dispersible film technologies, and an increase in the use of thin films for treating conditions like migraine and opioid dependence.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19730&type=smp

Which Drivers Are Supporting The Rise Of The Thin Film Drug Manufacturing Market?

The anticipated expansion of the global older adult demographic is set to fuel the growth of the thin-film drug manufacturing market in the future. This growth in the elderly population stems from factors such as longer life expectancies, progress in medicine, better nutrition and healthcare, and evolving family structures and societal standards. Thin film drug manufacturing addresses the demands of the increasing elderly demographic by providing benefits like enhanced medication adherence, user-friendliness, accurate dosage control, quick dissolution, and superior stability, collectively aiding in the better management of chronic illnesses and general health for seniors. As an illustration, the Population Reference Bureau, a US-based nonprofit, reported in January 2024 that the population of Americans aged 65 and above is predicted to climb from 58 million in 2022 to 82 million by 2050. Consequently, the expanding global elderly population is a key driver for the thin-film drug manufacturing market.

What Segments Are Identified Within The Structure Of The Thin Film Drug Manufacturing Market?

The thin film drug manufacturing market covered in this report is segmented –

1) By Type: Oral Thin Film, Transdermal Film, Other Types

2) By Disease Indication: Schizophrenia, Migraine, Opioid Dependence, Nausea And Vomiting, Other Disease Indications

3) By Distribution Channel: Hospital Pharmacies, Drug Stores, Retail Pharmacies, E-Commerce

Subsegments:

1) By Oral Thin Film: SubLingual Films, Buccal Films, Orodispersible Films, Taste-Masked Oral Films

2) By Transdermal Film: Adhesive Transdermal Films, Matrix Transdermal Films, Reservoir Transdermal Films, Drug-Eluting Transdermal Films

3) By Other Types: Topical Films, Ophthalmic Films, Intranasal Films, Veterinary Thin Films

Which Trends Are Influencing The Development Of The Thin Film Drug Manufacturing Market?

Leading companies within the thin film drug manufacturing market are prioritizing the creation of innovative products, such as oral thin film technologies, to bolster patient compliance and ease of administration. Oral thin film technologies involve developing rapidly dissolving films that deliver medication through the mouth’s mucous membranes for swift absorption. These films provide a practical, effective, and user-friendly substitute for traditional oral dosage forms like tablets and capsules. For example, in April 2023, IntelGenx Corporation, a Canada-based pharmaceutical company, revealed the Food and Drug Administration (FDA) approval of RIZAFILM for treating acute migraine. This new formulation enables quick dissolution and absorption, potentially offering faster relief for migraines compared to conventional tablets. This innovation not only improves bioavailability but also presents a more convenient, patient-friendly choice, thereby enhancing adherence. Ultimately, thin film technology significantly improves patient compliance and ease of use, establishing it as a more user-friendly method for managing acute migraine attacks.

Which Key Market Players Are Investing In Expansion And Innovation Within The Thin Film Drug Manufacturing Market?

Major companies operating in the thin film drug manufacturing market are Novartis AG, Merck KGaA, Dr. Reddy’s Laboratories, Indivior PLC, LTS Lohmann Therapie-Systeme AG, Aquestive Therapeutics, Zim Laboratories Ltd, Tapemark, AdhexPharma, MonoSol Rx, Aavishkar Oral Strips Pvt Ltd., APR Applied Pharma Research SA, Cynapsus Therapeutics Inc., Jurata Thin Film Inc., Nova Thin Film Pharmaceuticals LLC, Vektor Pharma TF GmbH, TFF Pharmaceuticals Inc., NAL Pharma, IntelGenx Corp, D.K. Livkon Healthcare Pvt Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/thin-film-drug-manufacturing-global-market-report

Which Regions Are Poised For Strategic Growth In The Thin Film Drug Manufacturing Market?

North America was the largest region in the thin film drug manufacturing market in 2025. The regions covered in the thin film drug manufacturing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Thin Film Drug Manufacturing Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19730&type=smp

Browse Through More Reports Similar to the Global Thin Film Drug Manufacturing Market 2026, By The Business Research Company

Psychedelic Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/psychedelic-drugs-global-market-report

Drug Screening Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Drug Discovery Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795